These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 9849987

  • 1. Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age.
    Carlsson RM, Claesson BA, Selstam U, Fagerlund E, Granström M, Blondeau C, Hoffenbach A.
    Pediatr Infect Dis J; 1998 Nov; 17(11):1026-33. PubMed ID: 9849987
    [Abstract] [Full Text] [Related]

  • 2. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
    Lagos R, Kotloff K, Hoffenbach A, San Martin O, Abrego P, Ureta AM, Pines E, Blondeau C, Bailleux F, Levine MM.
    Pediatr Infect Dis J; 1998 Apr; 17(4):294-304. PubMed ID: 9576383
    [Abstract] [Full Text] [Related]

  • 3. Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants.
    Tregnaghi M, Zambrano B, Santos-Lima E.
    Pediatr Infect Dis J; 2012 Jan; 31(1):e24-30. PubMed ID: 22157567
    [Abstract] [Full Text] [Related]

  • 4. Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis - hepatitis B virus - inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines?
    Usonis V, Bakasenas V.
    Eur J Pediatr; 1999 May; 158(5):398-402. PubMed ID: 10333123
    [Abstract] [Full Text] [Related]

  • 5. Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants.
    Pichichero ME, Latiolais T, Bernstein DI, Hosbach P, Christian E, Vidor E, Meschievitz C, Daum RS.
    Pediatr Infect Dis J; 1997 Sep; 16(9):863-70. PubMed ID: 9306481
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States.
    Klein NP, Abu-Elyazeed R, Cheuvart B, Janssens W, Mesaros N.
    Hum Vaccin Immunother; 2019 Sep; 15(4):809-821. PubMed ID: 30444673
    [Abstract] [Full Text] [Related]

  • 7. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
    Halperin SA, Tapiéro B, Dionne M, Meekison W, Diaz-Mitoma F, Zickler P, Rubin E, Embree J, Bhuyan P, Lee A, Li M, Tomovici A.
    Pediatr Infect Dis J; 2014 Jan; 33(1):73-80. PubMed ID: 24346596
    [Abstract] [Full Text] [Related]

  • 8. A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study.
    Vesikari T, Forstén A, Desole MG, Ferrera G, Caubet M, Mesaros N, Boutriau D.
    Pediatr Infect Dis J; 2013 May; 32(5):521-9. PubMed ID: 23190785
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine.
    Knutsson N, Trollfors B, Taranger J, Bergfors E, Sundh V, Lagergård T, Ostergaard E, Cicirello H, Käyhty H.
    Vaccine; 2001 Aug 14; 19(31):4396-403. PubMed ID: 11483264
    [Abstract] [Full Text] [Related]

  • 10. Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine.
    Dagan R, Igbaria K, Piglansky L, Melamed R, Willems P, Grossi A, Kaufhold A.
    Pediatr Infect Dis J; 1997 Dec 14; 16(12):1113-21. PubMed ID: 9427455
    [Abstract] [Full Text] [Related]

  • 11. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
    Halperin SA, King J, Law B, Mills E, Willems P.
    Clin Infect Dis; 1999 May 14; 28(5):995-1001. PubMed ID: 10452624
    [Abstract] [Full Text] [Related]

  • 12. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
    Lee CY, Thipphawong J, Huang LM, Lee PI, Chiu HH, Lin W, Debois H, Harrison D, Xie F, Barreto L.
    Pediatrics; 1999 Jan 14; 103(1):25-30. PubMed ID: 9917435
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age.
    Arístegui J, Dal-Ré R, Díez-Delgado J, Marés J, Casanovas JM, García-Corbeira P, De Frutos E, Van Esso D, Verdaguer J, De la Flor J, Moraga F, Boceta R, García-Martínez JA.
    Vaccine; 2003 Sep 08; 21(25-26):3593-600. PubMed ID: 12922087
    [Abstract] [Full Text] [Related]

  • 14. Antibody persistence to diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens, and Haemophilus influenzae type b following primary and first booster with pentavalent versus hexavalent vaccines.
    Wanlapakorn N, Sarawanangkoor N, Srimuan D, Thatsanathorn T, Thongmee T, Poovorawan Y.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2352909. PubMed ID: 38752802
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.
    Schmitt HJ, Zepp F, Müschenborn S, Sümenicht G, Schuind A, Beutel K, Knuf M, Bock HL, Bogaerts H, Clemens R.
    Eur J Pediatr; 1998 Mar 31; 157(3):208-14. PubMed ID: 9537487
    [Abstract] [Full Text] [Related]

  • 16. Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine.
    Gimenez-Sanchez F, Kieninger DM, Kueper K, Martinon-Torres F, Bernaola E, Diez-Domingo J, Steul K, Juergens C, Gurtman A, Giardina P, Liang JZ, Gruber WC, Emini EA, Scott DA, 501 and 006 study groups.
    Vaccine; 2011 Aug 11; 29(35):6042-8. PubMed ID: 21704105
    [Abstract] [Full Text] [Related]

  • 17. Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.
    Iro MA, Khatami A, Marshall AS, Pace D, Voysey M, McKenna J, Campbell D, Attard-Montalto S, Finn A, White C, Faust SN, Kent A, Heath PT, MacLeod E, Stanford E, Findlow H, Almond R, Bai X, Borrow R, Snape MD, Pollard AJ.
    Lancet Infect Dis; 2015 Feb 11; 15(2):172-80. PubMed ID: 25577661
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Pichichero ME, Bernstein H, Blatter MM, Schuerman L, Cheuvart B, Holmes SJ, 085 Study Investigators.
    J Pediatr; 2007 Jul 11; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
    [Abstract] [Full Text] [Related]

  • 19. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.
    Guerra FA, Blatter MM, Greenberg DP, Pichichero M, Noriega FR, Pentacel Study Group.
    Pediatrics; 2009 Jan 11; 123(1):301-12. PubMed ID: 19117896
    [Abstract] [Full Text] [Related]

  • 20. Combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C (HibMenC) or serogroup C and Y-tetanus toxoid conjugate (and HibMenCY) vaccines are well-tolerated and immunogenic when administered according to the 2,3,4 months schedule with a fourth dose at 12-18 months of age.
    Habermehl P, Leroux-Roels G, Sänger R, Mächler G, Boutriau D.
    Hum Vaccin; 2010 Aug 11; 6(8):640-51. PubMed ID: 20697200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.